Fig. 1
From: Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
CERS4 expression levels and prognostic significance in patients with breast cancer. (A)CERS4 expression in breast cancer tissue (tumor) and adjacent normal breast tissue. (B)CERS4 expression in LumA and PAM50 molecular breast cancer subtypes. (C) Kaplan−Meier plot showing survival among individuals with LumA breast cancer in the higher and lower CERS4 expression groups. The number of subjects is shown in parentheses. Two-tailed Student’s t-test was performed for (A and B). The log-rank test was performed for (C). Significance is indicated as follows: **P < 0.01 and #P < 0.0001